MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02740nam a22003017a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
20241029104114.0 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241029104804.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241029b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-0-07-183705-7 |
|
|---|
| International Standard Book Number |
0-07-183705-1 |
|
|---|
| International Standard Book Number |
978-0-07-163789-3 |
|
|---|
| International Standard Book Number |
0-07-163789-3 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
ddc |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
David R. Kohler |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Hematology - Oncology Therapy. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd Edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
New York | |
| Name of publisher, distributor, etc. |
McGraw-Hill Education | |
| Date of publication, distribution, etc. |
2024. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1889 Pages |
|
|---|
| Extent |
Includes Index |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens<br/><br/>A Doody's Core Title for 2021!<br/>More than 500 treatment regimens<br/><br/>Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology.<br/><br/>Hematology-Oncology Therapy is divided into three sections:<br/><br/>Oncology:<br/>Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens, drugs, and biological agents<br/><br/>Supportive Care, Drug Preparation, Complications, and Screening:<br/>Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more<br/><br/>Selected Hematologic Diseases:<br/>Delivers an authoritative guide to therapy for the principal diseases in consultative hematology<br/><br/>This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| General subdivision |
Medical / Emergency Medicine, Blood -- Diseases -- Treatment, Cancer -- Treatment, Drug Therapy, Combination -- methods, Hematologic Diseases, Hematology, Medical / Hematology, Medical / Oncology / General, Neoplasms -- therapy, Oncology, Blood -- Diseases. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
James N. Frame |
|
|---|
| Fuller form of name |
Michael M. Boyiadzis |
|
|---|
| Fuller form of name |
Tito Fojo |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
ddc |
| Koha item type |
E-BOOKS |
| Suppress in OPAC |
|
